Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SONIC trial in biologic- and immunomodulator-naive Crohn's disease
2004-002815-10Phase 3Completed
- Sponsor
- Janssen Biotech
- Start
- Mar 2005
- Modality
- Small Molecules, Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Crohn's disease comparing Infliximab monotherapy, Infliximab plus azathioprine and Azathioprine monotherapy (3 arms). Primary endpoint: Corticosteroid-free clinical remission at week 26. Started Mar 2005; status: completed.
02
Drugs
infliximabazathioprine
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on 2004-002815-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-002815-10.